Product Information
PHENOBARBITAL 97.2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1317 per EA under NDC 16571066801. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
97.2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/1/2020
Price Statistics
The NADAC for PHENOBARBITAL 97.2 MG TABLET has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1317 per EA |
|---|---|
| All-time high | $0.6410 (Jan 12, 2022) |
| All-time low | $0.1191 (Nov 20, 2024) |
| 52-week high | $0.2522 |
| 52-week low | $0.1317 |
| Median price | $0.2547 |
| Average price | $0.3038 |
| Largest weekly change | +115.4% (Aug 21, 2024) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 97.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 97.2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1317 per EA (NDC 16571066801), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 97.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 97.2 MG TABLET has declined 73.4%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 97.2 MG TABLET?
Since Aug 4, 2021, the NADAC for PHENOBARBITAL 97.2 MG TABLET has ranged from a low of $0.1191 (Nov 20, 2024) to a high of $0.6410 (Jan 12, 2022), with a median of $0.2547 per EA.
Are there cheaper alternatives to PHENOBARBITAL 97.2 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 97.2 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 97.2 MG TABLET?
PHENOBARBITAL 97.2 MG TABLET (NDC 16571066801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification